Could these small-cap growth stars fund your retirement?

These two growth stocks are looking to profit from their leading positions in niche markets.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Avon Rubber (LSE: AVON) is far from a household name but the share price of the £300m market cap manufacturer has nearly tripled over the past five years, which makes the company well worth taking a look at.

First off, this stellar share price performance isn’t without good cause as the company’s earnings per share have risen from 26.9p in 2012 to 74.2p last year. This growth has been driven by both organic expansion and a series of acquisitions that have increased the company’s product range for both its dairy solutions and protective masks for militaries and emergency personnel.

The European dairy market has been through the ringer of late as a global supply glut drove down prices and reduced demand for Avon’s products. However, management has taken this as an opportunity to increase market share and transition sales to its in-house-manufactured products that offer higher margins. With dairy prices beginning to rebound and farmers once again investing in their farms, Avon is already benefitting as dairy division revenue rose 22% year-on-year in H1 to £25.2m.

Sales of the group’s protective respiratory systems also rose by 22% to £55.9m as the US Department of Defense ordered high volumes of equipment and overseas demand increased substantially. Stripping out the positive effects of the weak pound did lower group revenue growth to 7%, but this is still a very healthy amount.

While group margins stayed level, profits and cash generation rose in line with sales growth and the company ended H1 with £12.6m in net cash, which supported a whopping 30% increase in the interim dividend. The company’s outlook over the long term will still be influenced by the cyclical nature of its two markets, but management is doing well to re-invest cash in expanding its portfolio of brands and pushing into new regions. With its shares priced at just 14 times forward earnings, I reckon investors would do well to dig deeper into Avon Rubber.

Finally turning a corner?

One small-cap offering a much higher ceiling but with much more risk for investors is Ceres Power (LSE: CWR). The company’s SteelCell fuel cell technology has long been lauded as the next big thing in a world seeking to lower carbon emissions, but so far the company has had little luck commercialising its product since going public over a decade ago.

That said, there have been tangible improvements in recent years under a new leadership team that has signed partnership agreements with major players in the automotive, energy and data centre sectors to utilise the SteelCell product to reduce operating costs and trim emissions.

The benefits of these agreements are starting to flow through to the company’s financial statements as revenue for the year to June more than doubled to £4.1m and its order book increased to £3.2m. Unfortunately, sales still do not cover operating expenditures and pre-tax losses for the year were £9.4m.

While losses are narrowing the company is still reliant on shareholders to fund itself through rights issues such as the one in October that raised £20m. Ceres’ SteelCell technology certainly has high potential to reduce energy costs for consumers and business alike, but investing in lossmaking small-caps is simply too risky for me so my interest will remain academic for now.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »